Goldman Sachs Group Inc Sana Biotechnology, Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 553,405 shares of SANA stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

553,405

Previous 553,405 -0.0%

Holding current value

$1.41 Million

Previous $929,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$1.65 - $4.3 $744,555 - $1.94 Million	-451,246 Reduced 44.92%	553,405 $929,000
Q4 2024 Feb 11, 2025	BUY	$1.6 - $4.36 $247,444 - $674,287	154,653 Added 18.19%	1,004,651 $1.64 Million
Q3 2024 Nov 14, 2024	BUY	$3.76 - $6.86 $122,809 - $224,061	32,662 Added 4.0%	849,998 $3.54 Million
Q2 2024 Aug 13, 2024	SELL	$5.23 - $10.44 $185,351 - $369,993	-35,440 Reduced 4.16%	817,336 $4.46 Million
Q1 2024 May 15, 2024	BUY	$4.2 - $11.27 $94,432 - $253,394	22,484 Added 2.71%	852,776 $8.53 Million
Q4 2023 Feb 13, 2024	BUY	$2.8 - $4.55 $603,820 - $981,207	215,650 Added 35.09%	830,292 $3.39 Million
Q3 2023 May 14, 2024	SELL	$3.77 - $6.23 $813,000 - $1.34 Million	-215,650 Reduced 25.97%	614,642 $2.38 Million
Q3 2023 Nov 14, 2023	SELL	$3.77 - $6.23 $922,168 - $1.52 Million	-244,607 Reduced 28.47%	614,642 $2.38 Million
Q2 2023 May 14, 2024	SELL	$3.22 - $7.53 $376,240 - $879,842	-116,845 Reduced 11.97%	859,249 $5.12 Million
Q2 2023 Aug 14, 2023	SELL	$3.22 - $7.53 $376,240 - $879,842	-116,845 Reduced 11.97%	859,249 $5.12 Million
Q1 2023 May 14, 2024	SELL	$3.11 - $4.92 $2.76 Million - $4.37 Million	-888,404 Reduced 47.65%	976,094 $3.19 Million
Q1 2023 May 11, 2023	SELL	$3.11 - $4.92 $2.76 Million - $4.37 Million	-888,404 Reduced 47.65%	976,094 $3.19 Million
Q4 2022 May 14, 2024	BUY	$3.19 - $6.46 $1.45 Million - $2.93 Million	453,630 Added 32.15%	1,864,498 $7.36 Million
Q4 2022 Feb 13, 2023	BUY	$3.19 - $6.46 $1.45 Million - $2.93 Million	453,630 Added 32.15%	1,864,498 $7.36 Million
Q3 2022 May 14, 2024	BUY	$5.58 - $9.04 $3.12 Million - $5.06 Million	559,841 Added 65.78%	1,410,868 $8.47 Million
Q3 2022 Nov 10, 2022	BUY	$5.58 - $9.04 $3.12 Million - $5.06 Million	559,841 Added 65.78%	1,410,868 $8.47 Million
Q2 2022 May 14, 2024	BUY	$4.12 - $9.35 $85,428 - $193,872	20,735 Added 2.5%	851,027 $5.47 Million
Q2 2022 Aug 15, 2022	BUY	$4.12 - $9.35 $1.05 Million - $2.39 Million	255,738 Added 42.96%	851,027 $5.47 Million
Q1 2022 May 16, 2022	BUY	$5.24 - $15.58 $1.08 Million - $3.21 Million	205,796 Added 52.84%	595,289 $4.92 Million
Q4 2021 Feb 14, 2022	BUY	$15.18 - $23.15 $1.76 Million - $2.69 Million	116,168 Added 42.5%	389,493 $6.03 Million
Q3 2021 Nov 10, 2021	BUY	$16.29 - $25.88 $4.45 Million - $7.07 Million	273,325 New	273,325 $6.16 Million

Others Institutions Holding SANA

# of Institutions

171

Shares Held

115M

Call Options Held

337K

Put Options Held

337K

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $485M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Sana Biotechnology, Inc. Transaction History